Montesinos-Rongen Manuel, Schmitz Roland, Courts Cornelius, Stenzel Werner, Bechtel Dörte, Niedobitek Gerald, Blümcke Ingmar, Reifenberger Guido, von Deimling Andreas, Jungnickel Berit, Wiestler Otmar D, Küppers Ralf, Deckert Martina
Department of Neuropathology, University of Cologne, Joseph-Stelzmann-Strasse 9, D-50931 Köln, Germany.
Am J Pathol. 2005 Jun;166(6):1773-9. doi: 10.1016/S0002-9440(10)62487-X.
Primary lymphomas of the central nervous system (PCNSLs) were investigated for their capacity to perform further maturation steps. We studied a series of 11 PCNSLs derived from immunocompetent patients for immunoglobulin (Ig) class switch recombination (CSR) by performing reverse transcriptase-polymerase chain reaction (RT-PCR) for transcripts of Ig constant region gene segments (IGHC). This analysis revealed exclusive transcription of IgM and IgD mRNA in the absence of IgG, IgA, or IgE transcription. This finding was corroborated at the protein level by the immunohistochemical demonstration of IgM on the surface of the tumor cells. The unexpected lack of CSR may be due to internal switch mu region deletions, which were detected in 7 of 11 cases. We also found that expression of activation-induced cytidine deaminase (AID), which is required for CSR and somatic hypermutation, was detectable by RT-PCR in 4 of 10 cases and by immunohistochemistry in one of three cases analyzed. This may indicate that ongoing somatic mutation, which is often observed in PCNSL, could be due to sustained AID expression in a fraction of cases and that intraclonal V gene diversity may occur in other cases at an earlier phase of tumor clone expansion, when AID may have been expressed.
对中枢神经系统原发性淋巴瘤(PCNSLs)进行了进一步成熟步骤能力的研究。我们通过对免疫球蛋白(Ig)恒定区基因片段(IGHC)转录本进行逆转录聚合酶链反应(RT-PCR),研究了一系列来自免疫功能正常患者的11例PCNSLs的免疫球蛋白类别转换重组(CSR)情况。该分析显示,在缺乏IgG、IgA或IgE转录的情况下,仅转录了IgM和IgD mRNA。在肿瘤细胞表面通过免疫组化证实IgM,这一发现得到了蛋白质水平的佐证。意外的是,CSR的缺乏可能是由于内部转换μ区域缺失,在11例中有7例检测到这种缺失。我们还发现,CSR和体细胞超突变所需的激活诱导胞苷脱氨酶(AID)的表达,通过RT-PCR在10例中的4例中可检测到,通过免疫组化在分析的3例中的1例中可检测到。这可能表明,在PCNSL中经常观察到的持续体细胞突变,在一部分病例中可能是由于AID的持续表达,而在肿瘤克隆扩增的早期阶段,当AID可能已经表达时,其他病例中可能会出现克隆内V基因多样性。